Urologic Diseases in America (UDA) is a reference standard on the prevalence, incidence, treatment and economic impact of urologic disease in the United States. Supported by the National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), the report was published in 2012 and is still considered current. An addendum was released in 2018 and is available online.
Coming Soon to AUAUniversity—New UDA Podcast Series
The AUA is partnering with researchers from Johns Hopkins University School of Medicine and Social & Scientific Systems to launch a series of podcast episodes through the AUAUniversity channel. Topics will include key findings from the UDA project across various disease states, and how best to use the UDA reference materials.
One of the preset aims of the UDA is to broaden the dissemination of the project’s findings beyond the typical research compendia format and making them more accessible to the urologic community. These large-scale, epidemiologic assessments inform the urologic community’s understanding of the scope of urologic disease that affects the US population. In this way, research efforts may be guided to areas of greatest impact.
In 2015, the NIDDK renewed the UDA with the following broad goals: to quantify the demographics, incidence, prevalence, and changes over time in benign urologic diseases; to identify variation in physician practice patterns, and to assess clinical and economic results of therapeutic interventions. This project was again renewed in 2019 with the Johns Hopkins and Social & Scientific Systems partnership design. The present UDA project will rely primarily on three datasets: the National Health and Nutrition Examination Survey (NHANES); the Centers for Medicare & Medicaid Services Medicare 5% Sample (CMS 5% Sample) for subjects aged >65 years; and the Optum© Clinformatics® Data Mart (CDM) dataset of privately insured subjects aged
Stay tuned for more details!
This project has been funded in whole or in part with Federal funds from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N94019F00260.